DelveInsight's Gastroesophageal Reflux Disease Market Insights report includes a comprehensive understanding of current treatment practices, gastroesophageal reflux disease emerging drugs, market ...

The gastroesophageal reflux disease market continues to be constrained by a limited number of approved treatment options and persistent unmet needs, particularly among patients who do not achieve ...

Experts highlight key themes from the ASCO GI Cancers Symposium, including the growing role of AI and an increased emphasis on patient-centered decision-making.

While heartburn medication can be a lifesaver for those suffering from gastric reflux, several studies over the years have ...

A new study published in Otolaryngology–Head and Neck Surgery reveals that glucagon-like peptide-1 receptor agonists ...

Research unveiled more possible safety signals and benefits ...

Across 8,584 U.S. acute care hospital units, higher nurse turnover is significantly associated with increased patient falls, according to a study published Dec. 29 in JAMA. Previous research has ...

American science took a beating this year, with cuts to funding, jobs and credibility. And yet, scientists persisted and made progress. These advances in 2025 spotlight how crucial it is to support ...

More than two dozen hospitals across Oregon were recently graded based on how safe they were in fall 2025. Leap Frog Group safety grades are released biannually after evaluating hospitals based on ...

Rhode Island Hospital has discharged seven of the nine patients from the shooting at Brown University on Saturday, Dec. 13, according to a spokesperson from the health system. As of 8:30 a.m. on Dec.

A patient in an open label extension study of Pfizer’s hemophilia treatment Hympavzi has died, the company and several hemophilia advocacy groups confirmed this week. Pfizer is now working with its ...

The drug targets a specific mutation that applies to only 2% of ALS patients. A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS ...